Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms

In prostate cancer, investigating aberrant gene expression may shed light on disease etiology. Here, the authors imputed expression transcriptome-wide for 233,955 European ancestry men, discovering and replicating the associations between prostatic expression for select genes and prostate cancer ris...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nima C. Emami, Linda Kachuri, Travis J. Meyers, Rajdeep Das, Joshua D. Hoffman, Thomas J. Hoffmann, Donglei Hu, Jun Shan, Felix Y. Feng, Elad Ziv, Stephen K. Van Den Eeden, John S. Witte
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/ea68863cb6aa42d9926f549fb3fe9771
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:In prostate cancer, investigating aberrant gene expression may shed light on disease etiology. Here, the authors imputed expression transcriptome-wide for 233,955 European ancestry men, discovering and replicating the associations between prostatic expression for select genes and prostate cancer risk, including the highly prevalent gene fusion partner TMPRSS2. The authors furthermore integrate diverse functional genomic datasets to interpret the epigenetic mechanisms by which the implicated risk variants and genes modulate disease risk.